Contrast

Contact

Share

MyChart

Help

Two Public Entrances Closing at Westerly Hospital

Thursday, August 31, 2017

WESTERLY, RHODE ISLAND, August 31, 2017 – In an effort to enhance patient, visitor and staff safety, beginning Wednesday, September 20, two access points will be closed permanently to the public -- the rear entrance of the hospital, known as the Henry J. Nardone Conference Center entrance, and the “blue awning” entrance at the front of the hospital. All patients and visitors will be required to enter the hospital building through the main entrance located at the front of the hospital.

“It is best practice for hospitals to have limited entrances and exits,” said Gary Young, director of public safety. “We have already secured access points in shipping and receiving. Securing these two remaining unmonitored entrances is an important step to making Westerly Hospital as safe as possible. We appreciate everyone’s cooperation with these changes.”

Both the Henry J. Nardone and “blue awning” entrances will continue to be accessible to hospital staff, physicians and volunteers. However, beginning on September 20, identification badges will be required for access.

The Henry J. Nardone Conference Center entrance will be functionable for public events.

Similar Articles

9/15/2021

Marna Borgstrom to retire in 2022 as CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – After more than 43 years of exceptional service, Marna P. Borgstom has announced her intent to retire as chief executive officer of Yale New Haven Health. Her retirement is effective on March 25 2022.

9/15/2021

Christopher O’Connor to become CEO of Yale New Haven Health

New Haven, CT (Sept. 15, 2021) – Christopher O’Connor has been named the CEO of Yale New Haven Health (YNHHS), effective March 25, 2022 when current CEO Marna P. Borgstrom retires, announced Vince Calarco, Chair of the YNHHS Board of Trustees. O’Connor currently serves as president of the Health System having been named to that position in August of 2020.

9/1/2021

Outpatient Monoclonal Antibody Treatment decreases hospitalization risk in COVID-19 patients

New Haven, CT (September 1, 2021) – While not a new treatment, monoclonal antibody therapy is being administered more regularly and effectively to patients with mild to moderate COVID-19 with excellent results.

Media Contact

Fiona Phelan
Tel. 860-271-4634
[email protected]